Category Archives: Blog

One-Year Survivor: The Joy and Vicissitudes of Surviving Cancer

This post was originally published on the author’s blog and reprinted with her consent. ​A year ago, I was undergoing cancer treatment. This month, I am celebrating my one-year survivorship. It is a big milestone on many levels. I underwent so much pain and so many sorrows. I am grateful for life, even though the hardships are not

Read More

Learn About Our Annual Volunteer recognition awardees

Each year, we ask our staff and community to nominate volunteers that stand out for the wonderful work they have done to support us.  Under normal circumstances, we would gather together to celebrate all of our volunteers who choose to donate their time and talents to us throughout the year. Without our volunteers, BACC would

Read More

From Sewing to Fight Cancer to Stitching to Fight COVID-19

Regina Bortolus epitomizes the humble ‘angel’ among us.  As a member of Mani di Angeli, a group within the Italian American Women’s Guild, she has led a group of dedicated women who have spent many hours creating and sewing dolls for pediatric wards at local hospitals and heart pillows for newly diagnosed clients of Bay

Read More

10 Ways You Can Support BACC

It is no secret that we absolutely love our BACC community. There’s a good reason that our Executive Director has been known to send emails and letters with the sign off “sending hugs!” It’s because, even before this pandemic, we knew we had the absolute best community. Now, during this time, our love and appreciation

Read More

Immunotherapy for Metastatic Triple-Negative Breast Cancer

Results from the IMpassion 130 clinical trial show that there is benefit to adding immunotherapy to chemotherapy in the treatment of metastatic triple-negative breast cancer (TNBC). This phase III clinical trial randomized 902 people with untreated metastatic TNBC to treatment with either chemotherapy or chemotherapy plus immunotherapy. The immunotherapy drug used in the study was

Read More

A New PI3K-Inhibitor for Advanced Estrogen Receptor-Positive Breast Cancer

Forty percent of advanced estrogen-receptor-positive (ER+) breast cancer patients have mutations that result in uncontrolled activation of the PI3K pathway. This pathway is involved in resistance to endocrine therapies and can promote the growth of ER+ breast cancer cells. SOLAR-1 is a phase III clinical trial of 572 patients with advanced ER+, HER2-negative breast cancer. The

Read More

Benefits of Oatmeal – With Recipe

Did You Know?A cup of oatmeal provides tryptophan – amino acid that converts to serotonin – the feel good brain hormone that in turn converts to melatonin – the sleep promoting hormone. The carbs in the oats promote the production of insulin which helps tryptophan get into the brain. And oats are high in Vitamin

Read More

The Most Beautiful Place (And You’re Invited)

“The purpose of a [clinician] or any human in general should not be to simply delay the death of a patient, but to increase the person’s quality of life.” – Patch Adams, MD If you distilled the sweetest goodness of medicine, you’d get the Bay Area Cancer Connections. Twenty-five years ago, a patient and a

Read More

Partial Breast Radiation

The standard of care after lumpectomy for early-stage breast cancer typically includes whole breast radiation (WBI) to reduce the risk of local recurrence. WBI is usually delivered daily for 3–6 weeks. Several recent studies have investigated the effectiveness of accelerated partial breast irradiation (APBI), which restricts the radiation to the area of the original tumor.

Read More

Delaying Chemotherapy for Triple-Negative Breast Cancer Impacts Outcome

Triple-negative breast cancer is characterized by the lack of the estrogen receptor, progesterone receptor, and HER2 receptor. Chemotherapy is the mainstay of systemic treatment for this type of cancer. A study led by researchers in Peru found that the time to initiation of chemotherapy is important for women diagnosed with stage II-III triple-negative breast cancer.

Read More